United Therapeutics Corporation annual gross profit for fiscal 2025 was $2.8 billion, an increase of 9.0% from $2.6 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Gross Profit (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gross Profit | $2.8B | $2.6B | $2.1B | $1.8B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Gross Profit (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit | $648M | $687M | $699M | $711M | $702M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More UTHR metrics: Revenue · Operating Income · Net Income · EPS · Free Cash Flow
All UTHR financial statements → Interactive UTHR charts →
About TickerBase · Data methodology & sources